H.C. Wainwright Reiterates Buy Rating on VYNE Therapeutics (VYNE)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: VYNE) | Delayed: 28.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.56 | 52 Week High | $ | |||
| Open | $28.56 | 52 Week Low | $ | |||
| Day High | $28.56 | P/E | N/A | |||
| Day Low | $28.56 | EPS | $ | |||
| Volume | 270,911 | |||||
